AVXT — AVAX Technologies Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.04m
- $0.62m
Annual income statement for AVAX Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2003 December 31st | 2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.931 | 1.69 | 1.62 | 0.735 | 0.617 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 4.2 | 5.03 | 5.47 | 6.23 | 7.31 |
| Operating Profit | -3.26 | -3.34 | -3.85 | -5.5 | -6.69 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.29 | -3.46 | -3.7 | -5.36 | -6.41 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.29 | -3.46 | -3.7 | -5.36 | -6.41 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -3.29 | -3.46 | -3.7 | -5.36 | -6.41 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -3.29 | -3.46 | -3.7 | -5.36 | -6.41 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.188 | -0.118 | -0.068 | -0.087 | -0.054 |
| Dividends per Share |